Literature DB >> 33910509

Effect of COVID-19 on childhood Mycoplasma pneumoniae infection in Chengdu, China.

Ying Zhang1,2, Yijie Huang2, Tao Ai2, Jun Luo2, Hanmin Liu3.   

Abstract

BACKGROUND: Following the outbreak of the COVID-19 pandemic, a change in the incidence and transmission of respiratory pathogens was observed. Here, we retrospectively analyzed the impact of COVID-19 on the epidemiologic characteristics of Mycoplasma pneumoniae infection among children in Chengdu, one of the largest cities of western China.
METHOD: M. pneumoniae infection was diagnosed in 33,345 pediatric patients with respiratory symptoms at the Chengdu Women's & Children's Central Hospital between January 2017 and December 2020, based on a serum antibody titer of ≥1:160 measured by the passive agglutination assay. Differences in infection rates were examined by sex, age, and temporal distribution.
RESULTS: Two epidemic outbreaks occurred between October-December 2017 and April-December 2019, and two infection peaks were detected in the second and fourth quarters of 2017, 2018, and 2019. Due to the public health response to COVID-19, the number of positive M. pneumoniae cases significantly decreased in the second quarter of 2020. The number of M. pneumoniae infection among children aged 3-6 years was higher than that in other age groups.
CONCLUSIONS: Preschool children are more susceptible to M. pneumoniae infection and close contact appears to be the predominant factor favoring pathogen transmission. The public health response to COVID-19 can effectively control the transmission of M. pneumoniae.

Entities:  

Keywords:  COVID-19 pandemic; Children; Mycoplasma pneumoniae; Western China

Year:  2021        PMID: 33910509     DOI: 10.1186/s12887-021-02679-z

Source DB:  PubMed          Journal:  BMC Pediatr        ISSN: 1471-2431            Impact factor:   2.125


  27 in total

Review 1.  Mycoplasma pneumoniae Infections in Childhood.

Authors:  T Prescott Atkinson; Ken B Waites
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

Review 2.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  Molecular characterization and analysis of Mycoplasma pneumoniae among patients of all ages with community-acquired pneumonia during an epidemic in China.

Authors:  Jiuxin Qu; Shuyan Chen; Fang Bao; Li Gu; Bin Cao
Journal:  Int J Infect Dis       Date:  2019-03-26       Impact factor: 3.623

4.  Epidemiology and Molecular Characteristics of Mycoplasma pneumoniae During an Outbreak of M. pneumoniae-associated Stevens-Johnson Syndrome.

Authors:  Louise K Francois Watkins; Daniel Olson; Maureen H Diaz; Xia Lin; Alicia Demirjian; Alvaro J Benitez; Jonas M Winchell; Christine C Robinson; Kirk A Bol; Mary P Glodé; Samuel R Dominguez; Lisa A Miller; Preeta K Kutty
Journal:  Pediatr Infect Dis J       Date:  2017-06       Impact factor: 2.129

5.  Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013.

Authors:  Maureen H Diaz; Alvaro J Benitez; Jonas M Winchell
Journal:  J Clin Microbiol       Date:  2014-10-29       Impact factor: 5.948

6.  Epidemiology and mechanism of drug resistance of Mycoplasma pneumoniae in Beijing, China: A multicenter study.

Authors:  Dong-Xing Guo; Wen-Juan Hu; Ran Wei; Hong Wang; Bao-Ping Xu; Wei Zhou; Shao-Jie Ma; Hui Huang; Xuan-Guang Qin; Yue Jiang; Xiao-Pei Dong; Xiao-Yan Fu; Da-Wei Shi; Liang-Yu Wang; A-Dong Shen; De-Li Xin
Journal:  Bosn J Basic Med Sci       Date:  2019-08-20       Impact factor: 3.363

Review 7.  Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.

Authors:  Hyunju Lee; Ki Wook Yun; Hoan Jong Lee; Eun Hwa Choi
Journal:  Expert Rev Anti Infect Ther       Date:  2017-12-11       Impact factor: 5.091

8.  Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012.

Authors:  Roger Dumke; Christiane Schnee; Mathias W Pletz; Jan Rupp; Enno Jacobs; Konrad Sachse; Gernot Rohde
Journal:  Emerg Infect Dis       Date:  2015-03       Impact factor: 6.883

9.  Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.

Authors:  Takaaki Tanaka; Tomohiro Oishi; Ippei Miyata; Shoko Wakabayashi; Mina Kono; Sahoko Ono; Atsushi Kato; Yoko Fukuda; Aki Saito; Eisuke Kondo; Hideto Teranishi; Yuhei Tanaka; Tokio Wakabayashi; Hiroto Akaike; Satoko Ogita; Naoki Ohno; Takashi Nakano; Kihei Terada; Kazunobu Ouchi
Journal:  Emerg Infect Dis       Date:  2017-10       Impact factor: 6.883

10.  Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea.

Authors:  Eun Lee; Chul-Hong Kim; Yong Ju Lee; Hyo-Bin Kim; Bong-Seong Kim; Hyung Young Kim; Yunsun Kim; Sangyoung Kim; Chorong Park; Ju-Hee Seo; In Suk Sol; Myongsoon Sung; Min Seob Song; Dae Jin Song; Young Min Ahn; Hea Lin Oh; Jinho Yu; Sungsu Jung; Kyung Suk Lee; Ju Suk Lee; Gwang Cheon Jang; Yoon-Young Jang; Eun Hee Chung; Hai Lee Chung; Sung-Min Choi; Yun Jung Choi; Man Yong Han; Jung Yeon Shim; Jin Tack Kim; Chang-Keun Kim; Hyeon-Jong Yang
Journal:  BMC Infect Dis       Date:  2020-02-12       Impact factor: 3.090

View more
  7 in total

1.  The Prevalence of Mycoplasma Pneumoniae Among Children in Beijing Before and During the COVID-19 Pandemic.

Authors:  Yuan Cheng; Yijing Cheng; Shuzhi Dai; Dongqing Hou; Menglei Ge; Yi Zhang; Lei Fan; Yingying Pei; Li Yu; Guanhua Xue; Lijuan Ma; Hongmei Sun
Journal:  Front Cell Infect Microbiol       Date:  2022-04-29       Impact factor: 6.073

2.  Bordetella pertussis, Chlamydia pneumoniae, and Mycoplasma pneumoniae Findings in Children During COVID-19 Pandemic in Finland.

Authors:  Ilari Kuitunen
Journal:  SN Compr Clin Med       Date:  2022-07-14

3.  Nonpharmaceutical interventions against the COVID-19 pandemic significantly decreased the spread of enterovirus in children.

Authors:  Junfeng Zhang; JiaJia Cao; Qing Ye
Journal:  J Med Virol       Date:  2022-05-03       Impact factor: 20.693

4.  Clinical Characteristics of Pediatric Respiratory Tract Infection and Respiratory Pathogen Isolation During the Coronavirus Disease 2019 Pandemic.

Authors:  Xifeng Tang; Ge Dai; Xiaohui Jiang; Ting Wang; Huiming Sun; Zhengrong Chen; Li Huang; Meijuan Wang; Canhong Zhu; Yongdong Yan; Wujun Jiang
Journal:  Front Pediatr       Date:  2022-01-05       Impact factor: 3.418

5.  Epidemiological Study on Mycoplasma pneumoniae and Chlamydia pneumoniae Infection of Hospitalized Children in a Single Center During the COVID-19 Pandemic.

Authors:  Fengqing Cai; Xinyi Shou; Qing Ye
Journal:  Front Cell Infect Microbiol       Date:  2022-03-21       Impact factor: 5.293

6.  Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021.

Authors:  Patrick M Meyer Sauteur; Michael L Beeton; Søren A Uldum; Nathalie Bossuyt; Melissa Vermeulen; Katherine Loens; Sabine Pereyre; Cécile Bébéar; Darja Keše; Jessica Day; Baharak Afshar; Victoria J Chalker; Gilbert Greub; Ran Nir-Paz; Roger Dumke
Journal:  Euro Surveill       Date:  2022-05

Review 7.  Changing Epidemiology of Respiratory Tract Infection during COVID-19 Pandemic.

Authors:  Hung-Jen Tang; Chih-Cheng Lai; Chien-Ming Chao
Journal:  Antibiotics (Basel)       Date:  2022-02-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.